Everolimus for Children With Recurrent or Progressive Low-Grade Glioma
Paper published on pediatric low grade gliomas in the Journal of Clinical Oncology by Sebastian Waszak, ISREC-EPFL and Sabine Mueller, UCSF
News from our member institutions
Major SNSF grant for CRTOH members
The Swiss National Science Foundation (SNSF) has awarded scientists from the University of Geneva (UNIGE) a Sinergia grant worth CHF 3 million.
Douglas Hanahan elected Foreign Member of the Royal Society
EPFL Professor Douglas Hanahan has been elected among eighty researchers as a Foreign Member of the Royal Society in the UK
Allies or enemies of cancer: the dual fate of neutrophils
An international team including scientists from the UNIGE and Harvard has discovered a new type of immune cell whose action is essential for the success of immunotherapies
Tumour avatars to fight colorectal cancer – Press Release – UNIGE
A UNIGE team has developed a new approach to customize treatments by testing them on artificial tumours
How genome doubling helps cancer develop
A joint project developed in Oricchio lab at EPFL & Ciriello lab at UNIL Read more via the links.
‘Meet the Author’ Webinar: Prof. Douglas Hanahan and Dr. Agnieszka Chryplewicz
See the entire interview by clicking the button below:
When researchers join forces in the fight against cancer
It’s often said that scientists and doctors are “waging war” against cancer. This kind of bellicose talk often frames discussions around a disease that affects more than 40,000 people and…
CD4 T – a new killer lymphocyte enters the ring
An alliance of researchers from member institutions of the SCCL discovers that CD4 T lymphocytes, which usually play a supporting role in fighting cancer cells, also have the power to…
Charting the immune landscape of brain cancers
For more than five years, Johanna Joyce and her team at the University of Lausanne have investigated the microenvironment of the major brain cancers in adults. As a result of…